U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ABSOLUTE
Molecular Formula C20H20N6O
Molecular Weight 360.4124
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of N-DESMETHYL GLASDEGIB

SMILES

O=C(N[C@@H]1CCN[C@H](C1)C2=NC3=C(N2)C=CC=C3)NC4=CC=C(C=C4)C#N

InChI

InChIKey=YCKOMQLGYYEBHS-CRAIPNDOSA-N
InChI=1S/C20H20N6O/c21-12-13-5-7-14(8-6-13)23-20(27)24-15-9-10-22-18(11-15)19-25-16-3-1-2-4-17(16)26-19/h1-8,15,18,22H,9-11H2,(H,25,26)(H2,23,24,27)/t15-,18-/m1/s1

HIDE SMILES / InChI

Molecular Formula C20H20N6O
Molecular Weight 360.4124
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Wed Apr 02 03:27:08 GMT 2025
Edited
by admin
on Wed Apr 02 03:27:08 GMT 2025
Record UNII
Q7K42LLA25
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
N-DESMETHYL GLASDEGIB
Common Name English
GLASDEGIB METABOLITE M3
Preferred Name English
UREA, N-((2R,4R)-2-(1H-BENZIMIDAZOL-2-YL)-4-PIPERIDINYL)-N'-(4-CYANOPHENYL)-
Systematic Name English
1-((2R,4R)-2-(1H-BENZIMIDAZOL-2-YL)-4-PIPERIDYL)-3-(4-CYANOPHENYL)UREA
Systematic Name English
Code System Code Type Description
CAS
2222533-66-4
Created by admin on Wed Apr 02 03:27:08 GMT 2025 , Edited by admin on Wed Apr 02 03:27:08 GMT 2025
PRIMARY
FDA UNII
Q7K42LLA25
Created by admin on Wed Apr 02 03:27:08 GMT 2025 , Edited by admin on Wed Apr 02 03:27:08 GMT 2025
PRIMARY
PUBCHEM
155804723
Created by admin on Wed Apr 02 03:27:08 GMT 2025 , Edited by admin on Wed Apr 02 03:27:08 GMT 2025
PRIMARY PUBCHEM
Related Record Type Details
PARENT -> METABOLITE
Glasdegib was the most abundant circulating component in plasma, constituting 69% of plasma radioactivity, with minor circulating metabolites each being <8% of radioactivity.